Reminder: Invitation to the Roche Diagnostics Investor Day 2021: Innovating diagnostics, shaping healthcare, changing lives
We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 March 2021 highlighting future growth drivers of the Division.
We will welcome you to the event in our new virtual 360° platform which will be accessible one day prior to the event (as of 15:00 CET). We would like to invite you to visit our virtual marketplace and participate in a self-guided virtual showroom tour. Stay tuned!
14:00-16:00 CET / 13:00-15:00 GMT
9:00-11:00am EDT / 6:00-8:00am PDT
The event will address the following topics:
Speakers will include:
The webinar will start with presentations, followed by a Q&A session (live access to the speakers).
Access to virtual event (pre-registration required):
Please pre-register for our webinar here until 15 March 2021.
A replay of the event will be available via > ir.roche.com
Karl Mahler Birgit Masjost
Head of Investor Relations and Investor Relations Officer
Roche Group Planning
|Roche Investor Relations|
| Dr. Karl Mahler|
Phone: +41 61 68-78503
| Dr. Sabine Borngräber|
Phone: +41 61 68-88027
| Dr. Bruno Eschli|
Phone: +41 61 68-75284
| Dr. Birgit Masjost|
Phone: +41 61 68-84814
| Dr. Gerard Tobin|
Phone: +41 61 68-72942
| Jon Kaspar Bayard|
Phone: +41 61 68-83894
|Investor Relations North America|
| Loren Kalm|
Phone: +1 650 225 3217
| Lisa Tuomi|
Phone: +1 650 467 8737